Association between local pediatric vaccination rates and patterns of pneumococcal disease in adults

Journal of Infectious Diseases

Volumn 213, Issue 4, 2016, Pages 509-515

  Pingali, Sundia Cassandra ^a   Warren, Joshua L ^a   Mead, Aimee M ^a   Sharova, Nancy ^b   Petit, Susan ^b   Weinberger, Daniel M ^a  

^a YALE UNIVERSITY   (United States)

^b Connecticut Department of Public Health ^*  (United States)

Author keywords

conjugate vaccine; herd immunity; indirect effects; pneumococcal

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLACK PERSON; CHILD; CHILD HEALTH CARE; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; HUMAN; INCOME; MALE; MEDICATION COMPLIANCE; MORBIDITY; PATIENT COMPLIANCE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REGISTER; SCHOOL CHILD; SEROTYPE; SOCIAL STATUS; UNITED STATES; VACCINATION; CLASSIFICATION; CONNECTICUT; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; SEROTYPING; STATISTICS AND NUMERICAL DATA; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CONNECTICUT; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; INFANT; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; YOUNG ADULT;

EID: 84960112620     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv431     Document Type: Article

References (12)

1. Feikin DR, Kagucia EW, Loo JD, et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013; 10: e1001517
2. Ardanuy C, Tubau F, Pallares R, et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 2009; 48: 57-64
3. Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294: 2043-51
4. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201: 32-41
5. Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged =65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2014; 63: 822-5
6. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA 2001; 285: 1729-35
7. Weinberger DM, Shapiro ED. Pneumococcal conjugate vaccines for adults. Hum Vaccin Immunother 2014; 10: 1334-6
8. Nuorti JP, Martin SW, Smith PJ, Moran JS, Schwartz B. Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts. Am J Prev Med 2008; 34: 46-53
9. Elam-Evans LD, Yankey D, Singleton JA, Kolasa M. National, state, and selected local area vaccination coverage among children aged 19-35 months-United States, 2013. MMWR Morb Mortal Wkly Rep 2014; 63: 741-8
10. Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. mBio 2011; 2: e00309-10
11. Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J 2014; 33: S161-71
12. Fleming-Dutra KE, Conklin L, Loo JD, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-Type nasopharyngeal carriage. Pediatr Infect Dis J 2014; 33: S152-60